Company / Current Assets
Serina Therapeutics, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$6.1M
FY2025
5-year range
$2.2M / $7.6M
FY2021-FY2025
Trend
+7.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $2M in FY2021 to $8M in FY2018.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of +21.6%.
Declined from $8M to $6M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +35.3%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +21.6%, indicating consistent growth.
- In FY2025, current assets increased 7.1% year-over-year.
- Peak current assets was recorded in FY2018.
- Lowest current assets in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.1M | +7.1% |
| FY2024 | $5.7M | -25.5% |
| FY2023 | $7.6M | +210.6% |
| FY2022 | $2.5M | +9.8% |
| FY2021 | $2.2M | -2.1% |
| FY2020 | $2.3M | -70.9% |
| FY2018 | $7.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026